Physician profile
Manorama Mathur
NPI 1245212570
$1,659.56
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $242 · 2021: $260 · 2022: $173 · 2023: $72.17 · 2024: $251 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $487.62 | 2019-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $223.14 | 2019-2025 | Bexsero, Rotarix |
| Pfizer INC. | $149.94 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $107.38 | 2019-2021 | |
| Seqirus USA INC | $106.20 | 2021-2025 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $104.96 | 2019 | |
| Amgen INC. | $104.19 | 2023-2024 | Repatha |
| Novo Nordisk INC | $74.79 | 2022 | |
| Amarin Pharma, INC. | $73.59 | 2021 | |
| Genentech USA, INC. | $66.24 | 2019-2021 | |
| Baxter Healthcare | $44.76 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Esperion Therapeutics, INC. | $39.68 | 2024 | Nexletol |
| Agios Pharmaceuticals, INC. | $24.60 | 2025 | Pyrukynd |
| Shield Therapeutics INC | $22.66 | 2022 | |
| Exact Sciences Corporation | $16.46 | 2025 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $13.35 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manorama Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.